ABEONA THERAPEUTICS INC. Increase (Decrease) in Deferred Revenue
ABEONA THERAPEUTICS INC. (ABEO) reported Increase (Decrease) in Deferred Revenue of $677.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $252.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $425.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for the quarter ending 2022-12-31 was $4.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for the quarter ending 2018-12-31 was $2.91M, a 18.16% increase year-over-year.
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for fiscal 2022 was -$292.00K.
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for fiscal 2018 was $296.00K, a 85.27% decline from fiscal 2017.
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for fiscal 2017 was $2.01M.
- ABEONA THERAPEUTICS INC. increase (decrease) in deferred revenue for fiscal 2016 was -$602.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $252.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $677.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $425.00K 10-Q · filed 2026-05-13 | |||
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$292.00K 10-K · filed 2023-03-29 | ||
| 2022-09-30 | -$296.00K 10-Q · filed 2022-11-14 | |||
| 2018-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.91M derived: sum of 2 quarters · filed 2020-03-16 | $2.36M derived: sum of 3 quarters · filed 2020-03-16 | $296.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$544.00K derived: sum of 2 quarters · filed 2018-11-09 | -$2.61M 10-Q · filed 2018-11-09 | -$151.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$2.61M 10-Q · filed 2018-08-09 | -$151.00K derived: sum of 3 quarters · filed 2020-03-16 | -$301.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | -$2.07M 10-Q · filed 2018-05-10 | $393.00K derived: sum of 2 quarters · filed 2020-03-16 | $243.00K derived: sum of 3 quarters · filed 2020-03-16 | $92.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.31M derived: sum of 2 quarters · filed 2020-03-16 | $2.16M derived: sum of 3 quarters · filed 2020-03-16 | $2.01M 10-K · filed 2020-03-16 |
| 2017-09-30 | -$150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$301.00K derived: sum of 2 quarters · filed 2018-11-09 | -$452.00K 10-Q · filed 2018-11-09 | -$602.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$302.00K 10-Q · filed 2018-08-09 | -$452.00K derived: sum of 3 quarters · filed 2019-03-18 | -$603.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | -$151.00K 10-Q · filed 2018-05-10 | -$301.00K derived: sum of 2 quarters · filed 2019-03-18 | -$452.00K derived: sum of 3 quarters · filed 2019-03-18 | -$602.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$301.00K derived: sum of 2 quarters · filed 2019-03-18 | -$451.00K derived: sum of 3 quarters · filed 2019-03-18 | -$602.00K 10-K · filed 2019-03-18 |
| 2016-09-30 | -$151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$301.00K derived: sum of 2 quarters · filed 2017-11-14 | -$452.00K 10-Q · filed 2017-11-14 | -$603.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | -$150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$301.00K 10-Q · filed 2017-08-14 | -$452.00K derived: sum of 3 quarters · filed 2017-08-14 | -$602.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$151.00K 10-Q · filed 2017-05-15 | -$302.00K derived: sum of 2 quarters · filed 2017-05-15 | -$452.00K derived: sum of 3 quarters · filed 2017-05-15 | -$603.00K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$301.00K derived: sum of 2 quarters · filed 2017-03-30 | -$452.00K derived: sum of 3 quarters · filed 2017-03-30 | -$602.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | -$150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$301.00K derived: sum of 2 quarters · filed 2016-11-14 | -$451.00K 10-Q · filed 2016-11-14 | -$602.00K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$301.00K 10-Q · filed 2016-08-15 | -$452.00K derived: sum of 3 quarters · filed 2016-08-15 | -$603.00K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$150.00K 10-Q · filed 2016-05-16 | -$301.00K derived: sum of 2 quarters · filed 2016-05-16 | -$452.00K derived: sum of 3 quarters · filed 2016-05-16 | -$602.00K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$302.00K derived: sum of 2 quarters · filed 2016-03-30 | -$452.00K derived: sum of 3 quarters · filed 2016-03-30 | -$349.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$301.00K derived: sum of 2 quarters · filed 2015-11-16 | -$198.00K 10-Q · filed 2015-11-16 | -$342.00K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | -$150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$47.00K 10-Q · filed 2015-08-14 | -$191.00K derived: sum of 3 quarters · filed 2015-08-14 | -$335.00K derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | $103.00K 10-Q · filed 2015-05-14 | -$41.00K derived: sum of 2 quarters · filed 2015-05-14 | -$185.00K derived: sum of 3 quarters · filed 2015-05-14 | $3.03M derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$288.00K derived: sum of 2 quarters · filed 2015-03-31 | $2.93M derived: sum of 3 quarters · filed 2015-03-31 | $2.87M 10-K · filed 2015-03-31 |
| 2013-09-30 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $3.07M derived: sum of 2 quarters · filed 2014-11-14 | $3.01M 10-Q · filed 2014-11-14 | $2.95M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $3.15M 10-Q · filed 2014-08-14 | $3.09M derived: sum of 3 quarters · filed 2014-08-14 | $3.03M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | -$62.00K 10-Q · filed 2014-05-12 | -$125.00K derived: sum of 2 quarters · filed 2014-05-12 | -$186.00K derived: sum of 3 quarters · filed 2014-05-12 | -$146.00K derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$124.00K derived: sum of 2 quarters · filed 2014-03-26 | -$84.00K derived: sum of 3 quarters · filed 2014-03-26 | -$596.00K 10-K · filed 2014-03-26 |
| 2012-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$21.00K derived: sum of 2 quarters · filed 2013-11-14 | -$533.00K 10-Q · filed 2013-11-14 | -$604.00K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$472.00K 10-Q · filed 2013-08-14 | -$543.00K derived: sum of 3 quarters · filed 2013-08-14 | -$1.48M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | -$512.00K 10-Q · filed 2013-05-15 | -$583.00K derived: sum of 2 quarters · filed 2013-05-15 | -$1.52M derived: sum of 3 quarters · filed 2013-05-15 | -$1.61M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | -$1.01M derived: sum of 2 quarters · filed 2013-03-20 | -$1.09M derived: sum of 3 quarters · filed 2013-03-20 | -$1.18M 10-K · filed 2013-03-20 |
| 2011-09-30 | -$936.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$1.02M derived: sum of 2 quarters · filed 2012-11-14 | -$1.11M 10-Q · filed 2012-11-14 | -$1.20M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | -$87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$173.00K 10-Q · filed 2012-08-14 | -$261.00K derived: sum of 3 quarters · filed 2012-08-14 | -$347.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | -$86.00K 10-Q · filed 2012-05-15 | -$174.00K derived: sum of 2 quarters · filed 2012-05-15 | -$260.00K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | -$174.00K derived: sum of 2 quarters · filed 2012-03-23 | -$348.00K 10-K · filed 2012-03-23 | |
| 2010-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$260.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$174.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |